Anti-Infective Agents Market Report, Size, and Top Players 2031
The anti-infective agents market size is projected to reach US$ 176.8 billion by 2031 from US$ 139.9 billion in 2023. The market is expected to register a CAGR of 3.2% during 2023–2031. The innovations in drug delivery systems are likely to remain key trends in the market.
Anti-Infective Agents Market Analysis
The rising incidence of infectious diseases drives the market's growth. As per the World Health Organization (WHO), in 2022, 10.6 million people suffered from tuberculosis across the globe, which is an increase from 10.3 million in 2021 and 10.0 million in 2020. Similarly, in 2022, the WHO estimated 249 million malaria cases worldwide. Such high incidence of infectious diseases increases the demand for anti-infective agents market.
Anti-Infective Agents Market Overview
Rising incidence of infectious diseases, increasing occurrence of drugs resistant pathogens, rising aging population, innovations in drug discovery and development, growing support from government initiatives and funding, increasing incidence of hospital acquired infections, robust pipeline of anti-infective drugs and rising public awareness regarding infectious diseases are factors driving the growth of the anti-infective agents market.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Anti-Infective Agents Market: Strategic Insights
Market Size Value in US$ 1,35,961.03 Million in 2022 Market Size Value by US$ 1,64,196.61 Million by 2028 Growth rate CAGR of 3.19% from 2022 to 2028 Forecast Period 2022-2028 Base Year 2022
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Anti-Infective Agents Market: Strategic Insights
| Market Size Value in | US$ 1,35,961.03 Million in 2022 |
| Market Size Value by | US$ 1,64,196.61 Million by 2028 |
| Growth rate | CAGR of 3.19% from 2022 to 2028 |
| Forecast Period | 2022-2028 |
| Base Year | 2022 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Anti-Infective Agents Market Drivers and Opportunities
Increasing Occurrence of Drugs Resistant Pathogens to Favor Market
Increasing antibiotic resistance pathogens increases the demand for new anti-infective agents. As per the Centers for Disease Control and Prevention, in the U.S., over 2.8 million antimicrobial-resistant infections occur every year. Similarly, as per the latest national surveillance data, UK Health Security Agency (UKHSA) annual conference, estimated that 58,224 people in England had an antibiotic resistant infection in 2022, that is a rise of 4% since 2021 (55,792).
Government Support and Initiatives likely to Create Growth Opportunities
Support from government organizations to develop new anti-infective drugs and distribute anti-infective agents is likely to favor the growth of the market. For instance, the Government of India, through the National AIDS and STD Control Programme (NACP), will provide high-quality anti-retroviral (ARV) medicines free of cost to people suffering from HIV from treatment facilities across the country.
Similarly, to end the HIV epidemic, the US Government invests billions to support HIV testing, prevention, treatment, and research initiatives across the country and the globe. The US government spends over US$ 28 billion per year to support the implementation of the Ending the HIV Epidemic in the US (EHE).
Anti-Infective Agents Market Report Segmentation Analysis
Key segments that contributed to the derivation of the anti-infective agents Market analysis are type, range, animal type, disease type, and end user.
- The anti-infective agents market, by type, is segmented into anti-bacterial, anti-viral, anti-fungal, and others. The anti-viral segment held the largest share of the market in 2022. The anti-viral segment is anticipated to register the highest CAGR in the market during the forecast period.
- Based on range, the global anti-infectives agents market is segmented into broad-spectrum, and narrow spectrum. In 2023, the narrow spectrum segment held the largest share of the market. However, the broad-spectrum segment is expected to witness growth in its demand at a fastest CAGR during the forecast period.
- By route of administration, the market is segmented into topical, oral, IV, and others. In 2023, the IV segment held the largest share of the market. However, the topical segment is expected to witness growth in its demand at a fastest CAGR during the forecast period.
- In terms of indication, the global anti-infectives agents market is segmented into HIV, tuberculosis, respiratory infection, pneumonia, and others. In 2022, the HIV segment is likely to hold the largest share of the market. Moreover, the same segment is expected to witness growth in its demand at a fastest CAGR during the forecast period.
- Based on distribution channel, the global anti-infectives agents market is segmented into hospital pharmacies, specialty pharmacies, e-commerce, and others. In 2022, the hospital pharmacies segment is likely to hold the largest share of the market. However, the e-commerce segment is anticipated to register the highest CAGR in the market during the forecast period.
Anti-Infective Agents Market Share Analysis by Geography
The geographic scope of the Anti-Infective Agents Market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
The North America anti-infective agents market has been segmented into the US, Canada, and Mexico. The increasing number of product approvals with growing research & development activities, and rising demand for advanced therapeutic solutions to treat chronic conditions and viral diseases are among the prominent factors propelling the market growth in this region.
Europe is the second-largest market owing to factors such as the rising geriatric population, increasing prevalence of chronic viral diseases, and high demand for developing new anti-viral drugs in the region. With USD 15.79 billion funded from 2007 to 2019 through the 7th Framework Program and Horizon 2020, in addition to the USD 1.1 billion pledged for coronavirus research, the EU plays a crucial role in funding and coordinating research on infectious diseases.
Anti-Infective Agents Market Report Scope
Anti-Infective Agents Market News and Recent Developments
The anti-infective agents market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the Anti-Infective Agents Market are listed below:
- Sandoz, a Novartis Division, announced its extension of collaboration agreement with Ares Genetics (Ares), aimed at driving cutting-edge digital solutions in the global fight against antimicrobial resistance (AMR). (Source: Sandoz, Press Release/Company Website/Newsletter, April 2022)
- Orchid Pharma has partnered with Cipla to distribute its breakthrough antibiotic combination across India. (Source: Cipla, Press Release/Company Website/Newsletter, July 2024)
Anti-Infective Agents Market Report Coverage and Deliverables
The “Anti-Infective Agents Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:
- Anti-Infective Agents Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Anti-Infective Agents Market trends as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Anti-Infective Agents Market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the Anti-Infective Agents Market
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Range, Route of Administration, Indication, and Distribution Channel
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, RoAPAC, RoE, RoMEA, RoSCAM, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
The anti-infective agents market is estimated to grow with a CAGR of 3.2% from 2023 to 2031.
The estimated value of the anti-infective agents market by 2031 is US$ 176.8 billion billion
The anti-infectives agents market majorly consists of the players such as Abbott, Allergan Plc., Astellas Pharma Inc., Merck & Co., Inc., Bayer AG, Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, F. HOFFMANN-LA ROCHE Ltd., Gilead Sciences, Inc., GlaxoSmithKline plc., Novartis AG among others.
Rising Investments in R&D Activities in Pharmaceutical Sector
The market drivers include rising prevalence of targeted diseases and rising government support for research activities and clinical trials are leading to increasing usage of anti-infectives agents market. However, emergence of anti-infective drugs resistance and their side effects is a key restraining factor for the market growth.
North America dominated the anti-infective agents market in 2023
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For